These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30654055)

  • 1. Solid nanoparticles for oral antimicrobial drug delivery: a review.
    Raza A; Sime FB; Cabot PJ; Maqbool F; Roberts JA; Falconer JR
    Drug Discov Today; 2019 Mar; 24(3):858-866. PubMed ID: 30654055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Toxicity Issues of Therapeutically Used Nanoparticles from the Oral Route.
    Lotfipour F; Shahi S; Farjami A; Salatin S; Mahmoudian M; Dizaj SM
    Biomed Res Int; 2021; 2021():9322282. PubMed ID: 34746313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoliposome-based antibacterial drug delivery.
    Hallaj-Nezhadi S; Hassan M
    Drug Deliv; 2015; 22(5):581-9. PubMed ID: 24313827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current state on the development of nanoparticles for use against bacterial gastrointestinal pathogens. Focus on chitosan nanoparticles loaded with phenolic compounds.
    Madureira AR; Pereira A; Pintado M
    Carbohydr Polym; 2015 Oct; 130():429-39. PubMed ID: 26076644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering strategies to enhance nanoparticle-mediated oral delivery.
    Yamanaka YJ; Leong KW
    J Biomater Sci Polym Ed; 2008; 19(12):1549-70. PubMed ID: 19017470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.
    Date AA; Hanes J; Ensign LM
    J Control Release; 2016 Oct; 240():504-526. PubMed ID: 27292178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 8. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.
    Dilnawaz F
    Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Oral Nano-Antibiotics for Bacterial Infection Therapy.
    Wu ZL; Zhao J; Xu R
    Int J Nanomedicine; 2020; 15():9587-9610. PubMed ID: 33293809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
    Ensign LM; Cone R; Hanes J
    Adv Drug Deliv Rev; 2012 May; 64(6):557-70. PubMed ID: 22212900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanodelivery systems for improved topical antimicrobial therapy.
    Basnet P; Škalko-Basnet N
    Curr Pharm Des; 2013; 19(41):7237-43. PubMed ID: 23489202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candesartan cilexetil loaded nanodelivery systems for improved oral bioavailability.
    Dudhipala N; Veerabrahma K
    Ther Deliv; 2017 Feb; 8(2):79-88. PubMed ID: 28088883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarrier systems for oral drug delivery: do we really need them?
    Bernkop-Schnürch A
    Eur J Pharm Sci; 2013 May; 49(2):272-7. PubMed ID: 23537503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination drug therapy via nanocarriers against infectious diseases.
    Walvekar P; Gannimani R; Govender T
    Eur J Pharm Sci; 2019 Jan; 127():121-141. PubMed ID: 30342173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial magnetic nanoparticles based-therapies for controlling infectious diseases.
    Rodrigues GR; López-Abarrategui C; de la Serna Gómez I; Dias SC; Otero-González AJ; Franco OL
    Int J Pharm; 2019 Jan; 555():356-367. PubMed ID: 30453018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained-release drug delivery of antimicrobials in controlling of supragingival oral biofilms.
    Steinberg D; Friedman M
    Expert Opin Drug Deliv; 2017 Apr; 14(4):571-581. PubMed ID: 27454813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current advances in drug delivery of nanoparticles for respiratory disease treatment.
    de Menezes BRC; Rodrigues KF; Schatkoski VM; Pereira RM; Ribas RG; Montanheiro TLDA; Thim GP
    J Mater Chem B; 2021 Feb; 9(7):1745-1761. PubMed ID: 33508058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric nanoparticle drug delivery technologies for oral delivery applications.
    Pridgen EM; Alexis F; Farokhzad OC
    Expert Opin Drug Deliv; 2015; 12(9):1459-73. PubMed ID: 25813361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoemulsion delivery systems for enhanced efficacy of antimicrobials and essential oils.
    Garcia CR; Malik MH; Biswas S; Tam VH; Rumbaugh KP; Li W; Liu X
    Biomater Sci; 2022 Feb; 10(3):633-653. PubMed ID: 34994371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.